TRINITY BIOTECH PLC
Income Statement
| Line Item | FY2016 | FY2015 |
|---|---|---|
| Revenue | $99.6M | $100.2M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | — | — |
| Operating Income | $-39.8M | $13.5M |
| Operating Margin | -40.0% | 13.5% |
| Interest Expense | $5.4M | $4.1M |
| Pretax Income | $-42.1M | $22.9M |
| Income Tax Expense | $-3.6M | $756.0K |
| Net Income | $-100.6M | $21.8M |
| Net Margin | -101.0% | 21.8% |
| EPS (Basic) | — | — |
| EPS (Diluted) | — | — |
| Shares Outstanding (Basic) | — | — |
| Shares Outstanding (Diluted) | — | — |
| Dividends Per Share | — | — |